Reem M Elshenawy

7PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsHaematological tumoursIndustrial molecular engineering of nucleic acids and proteinsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 22, 2026
A Novel Circulating microRNA Signature Panel as a Prognostic Biomarker for in Patients with Colorectal Cancer.

|Dec 22, 2024
Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.

Heba Shawky, Ashraf A Tabll, Reem M Elshenawy

|Dec 11, 2024
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.

Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy

|Nov 16, 2024
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.

Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy

|Jan 18, 2024
Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia.

Heba Shawky, Ashraf A Tabll, Reem M Elshenawy

|Apr 25, 2023
Overexpression of miRNA 26a and 26b with MMP-9 are valuable diagnostic biomarkers for colorectal cancer patients.

Sally Farouk, Reem El-Shenawy, Ahmed M Khairy

Pageof 2

Frequent Collaborators

4 joint publications

Rehab I Moustafa

4 joint publications

Naiera M Helmy

4 joint publications

Yasmine S El-Abd

4 joint publications

Ashraf A Tabll